Xi Shengyan, Yue Lifeng, Shi Mengmeng, Peng Ying, Xu Yangxinzi, Wang Xinrong, Li Qian, Kang Zhijun, Li Hanjing, Wang Yanhui
Department of Traditional Chinese Medicine, Medical College of Xiamen University, Xiamen, Fujian 361102, China.
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Evid Based Complement Alternat Med. 2016;2016:2974256. doi: 10.1155/2016/2974256. Epub 2016 May 11.
Chronic liver disease is one of the most common diseases that threaten human health. Effective treatment is still lacking in western medicine. Semen Persicae (Taoren) and Flos Carthami (Honghua) are known to relieve acute hepatic injury and inflammation, improve microcirculation, and reduce tissue fiber. The aim of our study is to investigate the potential mechanisms of Taoren-Honghua Herb Pair (THHP) in murine model of chronic liver disease caused by Carbon Tetrachloride (CCl4). Mice were randomly divided into seven groups: (1) blank, (2) model, (3) control (colchicine, 0.1 mg/kg), (4) THHP (5.53, 2.67, and 1.33 g/kg), and (5) Tao Hong Siwu Decoction (THSWD) (8.50 g/kg). Histological change and microvessels density were examined by microscopy. Hepatic function, serum fibrosis related factors, and hepatic vascular endothelial growth factor (VEGF) were measured with ELISA. VEGF, kinase insert domain-containing receptor (KDR), Flt-1, and Akt mRNA expression in hepatic tissue were determined with PCR. Tissues of Akt, pAkt, KDR, and Flt-1 were measured with western blotting. Data from this study showed that THHP improved hepatic function and restrained the hepatic inflammation and fibrosis. Its role in inhibiting pathological angiogenesis and hepatic fibrogenesis may be through affecting the angiogenesis-associated VEGF and its upstream and downstream signaling pathways.
慢性肝病是威胁人类健康的最常见疾病之一。西医仍缺乏有效的治疗方法。已知桃仁和红花可缓解急性肝损伤和炎症,改善微循环,并减少组织纤维化。我们研究的目的是探讨桃红药对在四氯化碳(CCl4)诱导的慢性肝病小鼠模型中的潜在作用机制。将小鼠随机分为七组:(1)空白组,(2)模型组,(3)对照组(秋水仙碱,0.1mg/kg),(4)桃红药对组(5.53、2.67和1.33g/kg),以及(5)桃红四物汤组(8.50g/kg)。通过显微镜检查组织学变化和微血管密度。用酶联免疫吸附测定法检测肝功能、血清纤维化相关因子和肝血管内皮生长因子(VEGF)。用聚合酶链反应测定肝组织中VEGF、含激酶插入结构域受体(KDR)、Flt-1和Akt的mRNA表达。用蛋白质印迹法检测Akt、pAkt、KDR和Flt-1的组织水平。本研究数据表明,桃红药对改善了肝功能,抑制了肝脏炎症和纤维化。其在抑制病理性血管生成和肝纤维化中的作用可能是通过影响血管生成相关的VEGF及其上下游信号通路来实现的。